Published in Pediatr Pulmonol on April 01, 2005
Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet (2006) 1.43
The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity. J Asthma (2012) 1.17
Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children. J Allergy Clin Immunol (2009) 1.11
Pediatric asthma: a different disease. Proc Am Thorac Soc (2009) 1.08
Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children. J Pediatr (2011) 1.05
Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol (2012) 1.02
Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet (2008) 0.96
Diagnostic accuracy of the bronchodilator response in children. J Allergy Clin Immunol (2013) 0.93
Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. J Allergy Clin Immunol (2008) 0.88
Perceived neighborhood safety and asthma morbidity in the school inner-city asthma study. Pediatr Pulmonol (2014) 0.83
The effects of indoor environmental exposures on pediatric asthma: a discrete event simulation model. Environ Health (2012) 0.81
Biomarkers in asthma: a real hope to better manage asthma. Clin Chest Med (2012) 0.80
Bisphenol A exposure is associated with decreased lung function. J Pediatr (2014) 0.78
Severe episodic viral wheeze in preschool children: High risk of asthma at age 5-10 years. Eur J Pediatr (2012) 0.77
International differences in asthma guidelines for children. Int Arch Allergy Immunol (2008) 0.76
Lung function changes from childhood to adolescence: a seven-year follow-up study. BMC Pulm Med (2015) 0.76
An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. Expert Rev Clin Immunol (2016) 0.75
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med (2010) 6.51
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol (2005) 4.50
Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med (2011) 4.09
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol (2006) 2.79
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol (2008) 2.56
The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov (2008) 2.45
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet (2004) 2.14
Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med (2004) 2.12
Particulate levels are associated with early asthma worsening in children with persistent disease. Am J Respir Crit Care Med (2006) 2.11
Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol (2006) 2.02
Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr (2003) 1.87
Spontaneous airway hyperresponsiveness in estrogen receptor-alpha-deficient mice. Am J Respir Crit Care Med (2006) 1.86
Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing? J Allergy Clin Immunol (2013) 1.82
The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials (2004) 1.79
Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med (2004) 1.71
Estrogen determines sex differences in airway responsiveness after allergen exposure. Am J Respir Cell Mol Biol (2007) 1.63
Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol (2007) 1.63
The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol (2005) 1.56
The role of IL-13 in established allergic airway disease. J Immunol (2002) 1.48
A comparison of the clinical characteristics of children and adults with severe asthma. Chest (2003) 1.42
Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol (2004) 1.36
The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med (2013) 1.36
Importance of the personal endotoxin cloud in school-age children with asthma. J Allergy Clin Immunol (2005) 1.33
Distribution and leukocyte contacts of gammadelta T cells in the lung. J Leukoc Biol (2005) 1.30
Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol (2004) 1.30
Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J Immunol (2004) 1.30
MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol (2003) 1.29
V gamma 4+ gamma delta T cells regulate airway hyperreactivity to methacholine in ovalbumin-sensitized and challenged mice. J Immunol (2003) 1.25
Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol (2004) 1.23
MHC class I-dependent Vgamma4+ pulmonary T cells regulate alpha beta T cell-independent airway responsiveness. Proc Natl Acad Sci U S A (2002) 1.23
IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am J Respir Crit Care Med (2007) 1.22
Jagged1 on dendritic cells and Notch on CD4+ T cells initiate lung allergic responsiveness by inducing IL-4 production. J Immunol (2009) 1.21
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol (2003) 1.20
Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8+ T cells and airway hyperresponsiveness. J Immunol (2005) 1.18
Is forced expiratory volume in one second the best measure of severity in childhood asthma? Am J Respir Crit Care Med (2004) 1.15
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc Natl Acad Sci U S A (2006) 1.14
Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. Am J Respir Crit Care Med (2005) 1.13
The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness. J Immunol (2006) 1.12
Airway hyperresponsiveness through synergy of gammadelta} T cells and NKT cells. J Immunol (2007) 1.11
Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol (2005) 1.10
Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. J Allergy Clin Immunol (2004) 1.10
The response of children with asthma to ambient particulate is modified by tobacco smoke exposure. Am J Respir Crit Care Med (2011) 1.09
The role of leukotriene B(4) in allergic diseases. Allergol Int (2008) 1.09
Should exhaled nitric oxide be part of routine asthma management? Ann Allergy Asthma Immunol (2012) 1.08
Quantitative computed tomography detects peripheral airway disease in asthmatic children. Pediatr Pulmonol (2005) 1.07
Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J (2005) 1.06
Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation. J Exp Med (2008) 1.05
Predictors of remitting, periodic, and persistent childhood asthma. J Allergy Clin Immunol (2010) 1.05
Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling. Am J Respir Cell Mol Biol (2004) 1.05
IKBKG (nuclear factor-kappa B essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function. J Allergy Clin Immunol (2008) 1.03
A randomized trial to test the effectiveness of art therapy for children with asthma. J Allergy Clin Immunol (2010) 1.03
Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am J Respir Crit Care Med (2003) 1.03
Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol (2008) 1.03
Animal models of airway sensitization. Curr Protoc Immunol (2007) 1.02
Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol (2012) 1.02
Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure. Am J Respir Crit Care Med (2005) 1.02
Natural history of asthma: persistence versus progression-does the beginning predict the end? J Allergy Clin Immunol (2008) 1.02
Plasticity of regulatory T cells: subversion of suppressive function and conversion to enhancement of lung allergic responses. J Immunol (2008) 1.02
IL-13 is essential to the late-phase response in allergic rhinitis. J Allergy Clin Immunol (2006) 1.01
CD8+ T cell-mediated airway hyperresponsiveness and inflammation is dependent on CD4+IL-4+ T cells. J Immunol (2007) 1.01
Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness. Am J Respir Crit Care Med (2005) 1.01
Racial differences in T-lymphocyte response to glucocorticoids. Chest (2005) 1.01
Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin Immunol (2004) 1.01
The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. Am J Respir Crit Care Med (2002) 1.00
Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am J Respir Crit Care Med (2003) 1.00
A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum Mutat (2008) 0.99
Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand. J Allergy Clin Immunol (2012) 0.99
Understanding asthma using animal models. Allergy Asthma Immunol Res (2009) 0.99
Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge. Am J Respir Cell Mol Biol (2006) 0.99
Role of the LTB4/BLT1 pathway in allergen-induced airway hyperresponsiveness and inflammation. Allergol Int (2006) 0.99
Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsiveness. J Immunol (2008) 0.98
Estimating effects of ambient PM(2.5) exposure on health using PM(2.5) component measurements and regression calibration. J Expo Sci Environ Epidemiol (2006) 0.98
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol (2008) 0.98
Histopathology of severe childhood asthma: a case series. Chest (2003) 0.97
Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors. BMC Immunol (2005) 0.97
Mismatched antigen prepares gamma delta T cells for suppression of airway hyperresponsiveness. J Immunol (2005) 0.96
Vgamma1+ T cells and tumor necrosis factor-alpha in ozone-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol (2008) 0.96
IL-10-treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice. J Allergy Clin Immunol (2007) 0.96
Pro: mice are a good model of human airway disease. Am J Respir Crit Care Med (2002) 0.95
Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates. Respir Med (2013) 0.95
Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness. J Immunol (2002) 0.94
Antigen specificity is not required for modulation of lung allergic responses by naturally occurring regulatory T cells. J Immunol (2009) 0.94
Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med (2003) 0.94
NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide. Int Arch Allergy Immunol (2009) 0.94
Leukotriene B4 release from mast cells in IgE-mediated airway hyperresponsiveness and inflammation. Am J Respir Cell Mol Biol (2008) 0.93
Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors. J Immunol (2003) 0.93
Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation. J Immunol (2009) 0.93
Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Derm Venereol (2007) 0.93
Corticosteroids enhance CD8+ T cell-mediated airway hyperresponsiveness and allergic inflammation by upregulating leukotriene B4 receptor 1. J Allergy Clin Immunol (2008) 0.93
Leukotriene B4 receptor 1 expression on dendritic cells is required for the development of Th2 responses and allergen-induced airway hyperresponsiveness. J Immunol (2008) 0.92
RANTES (CCL5) regulates airway responsiveness after repeated allergen challenge. Am J Respir Cell Mol Biol (2006) 0.92
Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice. J Allergy Clin Immunol (2007) 0.92
Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. J Allergy Clin Immunol (2006) 0.92